T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
H&R Block
HRB
$6.76B
| $15M | ﹤0.01% |
506,448
+54,600
| +12% | +$1.71M |
|
|
VAR
1227
DELISTED
Varian Medical Systems, Inc.
VAR
| $14.9M | ﹤0.01% |
201,597
+2,509
| +1% | +$196K |
|
1228
Quanta Services
PWR
$101B
| $14.9M | ﹤0.01% |
517,030
-1,269,651
| -71% | -$37.1M |
|
|
VIRX
1229
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $14.9M | ﹤0.01% |
23,532
-2,162
| -8% | -$1.15M |
|
|
TEN
1230
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $14.8M | ﹤0.01% |
257,050
+14,200
| +6% | +$837K |
|
1231
Ralph Lauren
RL
$23.1B
| $14.8M | ﹤0.01% |
111,530
+11,380
| +11% | +$1.54M |
|
1232
Fluor
FLR
$7B
| $14.8M | ﹤0.01% |
278,274
-3,690
| -1% | -$213K |
|
1233
Oneok
OKE
$58.4B
| $14.7M | ﹤0.01% |
371,470
+2,600
| +0.7% | +$115K |
|
|
FCE.A
1234
DELISTED
Forest City Realty Trust, Inc.
FCE.A
| $14.6M | ﹤0.01% |
660,830
+112,400
| +20% | +$2.66M |
|
|
EFOR
1235
Everforth Inc
EFOR
$1.37B
| $14.6M | ﹤0.01% |
371,010
-142,980
| -28% | -$5.46M |
|
1236
Freshpet
FRPT
$3.5B
| $14.5M | ﹤0.01% |
780,240
+400,400
| +105% | +$8.37M |
|
1237
Goodyear
GT
$1.78B
| $14.5M | ﹤0.01% |
479,486
+2,810
| +0.6% | +$83.5K |
|
|
CPHD
1238
DELISTED
Cepheid Inc
CPHD
| $14.4M | ﹤0.01% |
236,056
+20,992
| +10% | +$1.2M |
|
|
WBMD
1239
DELISTED
WebMD Health Corp.
WBMD
| $14.4M | ﹤0.01% |
325,870
+23,700
| +8% | +$1.08M |
|
|
SWI
1240
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $14.4M | ﹤0.01% |
312,200
+40,100
| +15% | +$1.97M |
|
1241
Walker & Dunlop
WD
$1.47B
| $14.2M | ﹤0.01% |
530,443
+5,200
| +1% | +$115K |
|
|
INFA
1242
DELISTED
INFORMATICA CORP
INFA
| $14.2M | ﹤0.01% |
292,498
-50,300
| -15% | -$2.42M |
|
|
GRA
1243
DELISTED
W.R. Grace & Co.
GRA
| $14.2M | ﹤0.01% |
141,081
-4,869
| -3% | -$480K |
|
1244
Koppers
KOP
$874M
| $14.1M | ﹤0.01% |
569,381
-558,447
| -50% | -$13.5M |
|
1245
Greif
GEF
$5.03B
| $14.1M | ﹤0.01% |
392,070
+379,970
| +3,140% | +$15.1M |
|
|
SCG
1246
DELISTED
Scana
SCG
| $13.9M | ﹤0.01% |
274,568
+23,679
| +9% | +$1.25M |
|
|
PPLI
1247
People Inc
PPLI
$3.01B
| $13.9M | ﹤0.01% |
975,145
-610
| -0.1% | -$8.09K |
|
1248
Donaldson
DCI
$11.1B
| $13.8M | ﹤0.01% |
384,642
-7,100
| -2% | -$259K |
|
1249
Avis
CAR
$4.84B
| $13.8M | ﹤0.01% |
312,000
-9,800
| -3% | -$517K |
|
1250
Jefferies Financial Group
JEF
$12.9B
| $13.8M | ﹤0.01% |
632,622
+70,379
| +13% | +$1.5M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.